Drug Shortage Report for HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
Report ID | 154024 |
Drug Identification Number | 02303108 |
Brand name | HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) |
Common or Proper name | HEPARIN SODIUM |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | HEPARIN SODIUM |
Strength(s) | 10000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
Packaging size | 50ML 1LIVI |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-02-01 |
Estimated end date | 2023-01-13 |
Actual end date | 2023-01-18 |
Shortage status | Resolved |
Updated date | 2023-01-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v30 | 2023-01-19 | French | Compare |
v29 | 2023-01-19 | English | Compare |
v28 | 2022-12-28 | French | Compare |
v27 | 2022-12-28 | English | Compare |
v26 | 2022-11-28 | French | Compare |
v25 | 2022-11-28 | English | Compare |
v24 | 2022-11-02 | French | Compare |
v23 | 2022-11-02 | English | Compare |
v22 | 2022-10-12 | French | Compare |
v21 | 2022-10-12 | English | Compare |
v20 | 2022-09-21 | French | Compare |
v19 | 2022-09-21 | English | Compare |
v18 | 2022-09-21 | French | Compare |
v17 | 2022-09-21 | English | Compare |
v16 | 2022-08-18 | French | Compare |
v15 | 2022-08-18 | English | Compare |
v14 | 2022-08-03 | French | Compare |
v13 | 2022-08-03 | English | Compare |
v12 | 2022-07-06 | French | Compare |
v11 | 2022-07-06 | English | Compare |